Disclosure Of First-Time Adoption [Text Block]

ABIVAX - Filing #5984181

Concept 2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
Disclosure of first-time adoption [text block]
Disclosure of comparative information prepared under previous GAAP [text block]
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity
262 637 EUR
478 905 EUR
633,000 EUR
75,000 EUR
40 584 EUR
40 584 EUR
176 242 EUR
196 010 EUR
135 209 EUR
147 740 EUR
478 218 EUR
629,000 EUR
112,000 EUR
196 010 EUR
7 189 EUR
82 770 EUR
60 740 EUR
150 476 EUR
223,000 EUR
EUR
7 189 EUR
42 452 EUR
25 934 EUR
39 361 EUR
107 578 EUR
EUR
168,000 EUR
Comprehensive income
176 242 EUR
31,000 EUR
EUR
EUR
187,000 EUR
176 461 EUR
147 516 EUR
147 740 EUR
112,000 EUR
EUR
112,000 EUR
EUR
EUR
60 506 EUR
235,000 EUR
60 740 EUR
EUR
EUR
Profit (loss)
176 242 EUR
EUR
176 242 EUR
EUR
EUR
EUR
176 242 EUR
147 740 EUR
147 740 EUR
EUR
147 740 EUR
EUR
EUR
EUR
EUR
60 740 EUR
EUR
60 740 EUR
EUR
EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.